Mira Pharmaceuticals, Inc.
- Last sale
- Nov 6, 2026 · +0.89%
- Market cap
- $23.32M
- 42.02M shares
- Filings
- 200
—
—
—Q2 2026N/M FY25 yoy
—
—
——
—
—Q2 2026N/M FY25 yoy
Q2 2026+124.0% FY25 yoy
- $23.32M
- —
- —
- 3.4×
- —
- —
FY2025 figures · derived
Price
Nov 6, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Net Interest Income
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $98,911 | reported | |
| FY 2024 | 2024-12-31 | $165,669 | reported |
Pharmaceutical preparations
Mira Pharmaceuticals, Inc. is the 379th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
ETSTEarth Science Tech, Inc.$35.7M7.8%10.2%$25.9MIXHLIncannex Healthcare Inc.$0.0100.0%—$25.5MCPHIChina Pharma Holdings, Inc.$4.1M8.5%76.9%$24.1MRNAZTranscode Therapeutics, Inc.———$23.7M
MIRAMira Pharmaceuticals, Inc. (this company)———$23.3M
SHPHShuttle Pharmaceuticals Holdings, Inc.———$22.7MFLNAFilana Therapeutics, Inc.———$22.1MIGCIGC Pharma, Inc.Fiscal 2025 figures———$21.9MCELUCelularity Inc$26.6M51.0%345.4%$21.8MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Mira Pharmaceuticals, Inc. · CIK 1904286 · Engraved from SEC EDGAR